Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1415 clinical trials
Blood Biomarker of Alzheimer's Disease (AD)

The identification and validation of high throughput biomarkers to measure disease progression (as well as identify pre-clinical disease onset) is critical to the development of disease-modifying or even preventative therapies. In this study, we are testing a blood biomarker for stratification of Alzheimer's disease patients and healthy volunteers.

memory disorders
alzheimer's disease
cancer
blood test
  • 0 views
  • 16 Feb, 2024
  • 1 location
Physical Activity Level in Patients With OSAS During Covid-19 Pandemic

As long as the people stay at home because of the Covid 19 outbreak, the investigators assume that the sleep quality of OUAS patients, like everyone else, and the sleep quality of COVID-19 outbreak are reduced due to anxiety and anxiety in people.

  • 0 views
  • 05 Aug, 2020
Which Type of Laparoscopic Colectomy Right or Left Have Better Postoperative Outcomes for the Patients?

Objective: To compare perioperative morbidity of the right versus left colectomy for cancer, as well as the quality of laparoscopic oncologic resection of both procedures. Methods: Retrospective analysis of prospectively collected data from patients operated at the University of So Paulo School of Medicine, between 2006 and 2016.

  • 0 views
  • 05 Aug, 2020
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus (LES-HYDROXY)

These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

  • 0 views
  • 08 Dec, 2023
  • 1 location
Analysis Of The Anxiety-Depressive Pattern Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24)

The aim of this study is the evaluation of psychological aspects, such as anxiety-depressive patterns, quality of life, personality and other psychopathological syndromes of patients who receive a diagnosis of pancreatic cancer and who face chemotherapy treatment, radio-chemotherapy or surgery

ductal adenocarcinoma
pancreatic ductal adenocarcinoma
cancer
pancreatic cancer
adenocarcinoma
  • 0 views
  • 05 Aug, 2020
GORE VIABAHN Endoprosthesis Post-Marketing Surveillance Study

This study will confirm the efficacy and safety in the clinical setting after the launch of the GORE VIABAHN stent graft (hereafter referred to as "Viabahn") for the treatment of patients with stenosis or occlusion at the venous anastomosis of synthetic arteriovenous access graft.

  • 0 views
  • 05 Aug, 2020
Impact of Obsidian ASG on Anastomotic Healing

The literature identifies the leak rate for colorectal operations as 3-39%.

  • 0 views
  • 05 Aug, 2020
Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients

Carbon dioxide in patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is eliminated via respirator as well as via the oxygenator's membrane of the ECMO machine. Consequently, monitoring of end-tidal carbon dioxide tensions is limited, which can result in marked swings towards non-physiological values.

  • 0 views
  • 05 Aug, 2020
Hypertension Management in Family Practice  

The population age 65 years or older numbered 46.2 million in 2014 and they represent 14.5% of the US population, the older population in 2030 is projected to be more than twice as large as in 2000, growing from 35 million to 74 million and representing 21 percent of the …

Online studies
  • 0 views
  • 08 Nov, 2022
  • 3 locations
LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

To determine whether in patients with EGFR mutated advanced NSCLC and osimertinib as first-line treatment, the (repeated) use of LAT to 3 OP lesions and continuation of first-line osimertinib, improves the median progression-free survival by more than 3 months (i.e.

  • 0 views
  • 16 Feb, 2024
  • 1 location